Published in Neural Regen Res on May 01, 2015
Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment. Sci Rep (2017) 0.75
Nanotechnology and bio-functionalisation for peripheral nerve regeneration. Neural Regen Res (2015) 0.75
Electrospun Fibers for Drug Delivery after Spinal Cord Injury and the Effects of Drug Incorporation on Fiber Properties. Cells Tissues Organs (2016) 0.75
An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling. Nat Commun (2017) 0.75
Glial inhibition of CNS axon regeneration. Nat Rev Neurosci (2006) 6.91
Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell (2012) 5.15
Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol (2007) 3.06
Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev (2011) 2.86
Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J Neurosci (2008) 2.79
Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus (2008) 2.37
Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells (2006) 2.37
Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol (2007) 2.30
Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab (2012) 2.20
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (2006) 2.07
Beta1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development (2004) 2.04
Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord (2004) 2.01
Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab (2003) 2.01
Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy (2009) 1.98
A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma (2010) 1.95
Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med (2010) 1.89
Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells (2004) 1.83
Adult neurogenesis: integrating theories and separating functions. Trends Cogn Sci (2010) 1.83
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials (2008) 1.58
Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci (2012) 1.55
A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma (2010) 1.54
Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells (2007) 1.53
Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ (2002) 1.52
Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci (2008) 1.49
From basics to clinical: a comprehensive review on spinal cord injury. Prog Neurobiol (2013) 1.47
Design strategies of tissue engineering scaffolds with controlled fiber orientation. Tissue Eng (2007) 1.40
Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals. J Neurosci (2010) 1.36
Stem cell therapies for spinal cord injury. Nat Rev Neurol (2010) 1.35
Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells (2011) 1.34
Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant (2008) 1.34
Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant (2006) 1.33
Induction of neurogenesis in nonconventional neurogenic regions of the adult central nervous system by niche astrocyte-produced signals. Stem Cells (2008) 1.32
Segregation of human neural stem cells in the developing primate forebrain. Science (2001) 1.29
Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience (2008) 1.28
Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates. Mol Cell Neurosci (2003) 1.25
An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp Neurol (2006) 1.25
Advances in stem cell therapy for spinal cord injury. J Clin Invest (2012) 1.24
The control of neural stem cells by morphogenic signals. Curr Opin Genet Dev (2002) 1.22
Templated agarose scaffolds support linear axonal regeneration. Tissue Eng (2006) 1.21
Causes of spinal cord injury. Top Spinal Cord Inj Rehabil (2013) 1.21
Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A (2009) 1.21
Long-term survival and outgrowth of mechanically engineered nervous tissue constructs implanted into spinal cord lesions. Tissue Eng (2006) 1.20
Don't fence me in: harnessing the beneficial roles of astrocytes for spinal cord repair. Restor Neurol Neurosci (2008) 1.19
Home at last: neural stem cell niches defined. Cell Stem Cell (2009) 1.19
Polypyrrole-coated electrospun PLGA nanofibers for neural tissue applications. Biomaterials (2009) 1.18
The burden of acute traumatic spinal cord injury among adults in the united states: an update. J Neurotrauma (2014) 1.16
Primate embryonic stem cell-derived neuronal progenitors transplanted into ischemic brain. J Cereb Blood Flow Metab (2006) 1.16
Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J Biomed Sci (2009) 1.16
Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury. Eur J Neurosci (2013) 1.12
Local and remote growth factor effects after primate spinal cord injury. J Neurosci (2010) 1.12
Hyaluronic acid based scaffolds for tissue engineering--a review. Carbohydr Polym (2012) 1.11
An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev (2012) 1.11
Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery (2012) 1.10
Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials (2005) 1.09
Biomaterials for the central nervous system. J R Soc Interface (2008) 1.08
A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. Brain Res (2003) 1.08
Delivery of autologous bone marrow precursor cells into the spinal cord via lumbar puncture technique in patients with spinal cord injury: a preliminary safety study. Exp Hematol (2006) 1.07
Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials (2010) 1.07
Oligodendrocyte-protection and remyelination post-spinal cord injuries: a review. Prog Neurobiol (2012) 1.05
Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury. Exp Neurol (2005) 1.05
Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials (2005) 1.04
Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett (2009) 1.03
Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord (2006) 1.03
The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury. Biomaterials (2010) 1.03
Rapidly in situ-forming degradable hydrogels from dextran thiols through Michael addition. Biomacromolecules (2007) 1.02
Injectable hydrogel materials for spinal cord regeneration: a review. Biomed Mater (2012) 1.02
Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009) 1.01
Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics (2011) 1.01
Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy (2009) 1.00
Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J Neurosurg Spine (2012) 1.00
Effect of body temperature on chondroitinase ABC's ability to cleave chondroitin sulfate glycosaminoglycans. J Neurosci Res (2007) 1.00
Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J Biomed Mater Res A (2010) 1.00
Neural tissue engineering using embryonic and induced pluripotent stem cells. Stem Cell Res Ther (2011) 0.99
Cell-laden hydrogel constructs of hyaluronic acid, collagen, and laminin for neural tissue engineering. Tissue Eng Part A (2010) 0.99
Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair. J Biomed Mater Res A (2011) 0.99
Nanofibrous collagen nerve conduits for spinal cord repair. Tissue Eng Part A (2012) 0.98
The effect of neurotrophin-3/chitosan carriers on the proliferation and differentiation of neural stem cells. Biomaterials (2009) 0.97
Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury. PLoS One (2012) 0.97
Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells (2006) 0.97
Three-dimensional nanofibrous scaffolds incorporating immobilized BDNF promote proliferation and differentiation of cortical neural stem cells. Stem Cells Dev (2010) 0.97
Manufacture of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel tubes for use as nerve guidance channels. Biomaterials (2002) 0.96
Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury. J Neurosci Res (2004) 0.96
Biodegradable poly-beta-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair. Biomaterials (2008) 0.95
Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials (2013) 0.95
Combination treatment with chondroitinase ABC in spinal cord injury--breaking the barrier. Neurosci Bull (2013) 0.95
Nanomaterials design and tests for neural tissue engineering. Chem Soc Rev (2012) 0.95
Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng Part A (2009) 0.94
Enhanced regeneration in spinal cord injury by concomitant treatment with granulocyte colony-stimulating factor and neuronal stem cells. J Clin Neurosci (2008) 0.94
A functionalizable reverse thermal gel based on a polyurethane/PEG block copolymer. Biomaterials (2011) 0.91
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc Natl Acad Sci U S A (2001) 0.91
Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection. Tissue Eng Part A (2008) 0.91
Co-transplantation of neural stem cells and NT-3-overexpressing Schwann cells in transected spinal cord. J Neurotrauma (2007) 0.91
Technical aspects of spinal cord injections for cell transplantation. Clinical and translational considerations. Brain Res Bull (2010) 0.91
Mats made from fibronectin support oriented growth of axons in the damaged spinal cord of the adult rat. Exp Neurol (2003) 0.91
Rho-ROCK inhibition in the treatment of spinal cord injury. World Neurosurg (2013) 0.90
Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells Dev (2007) 0.90
Biomaterials combined with cell therapy for treatment of spinal cord injury. Regen Med (2012) 0.90
Endogenous neural progenitor cells as therapeutic target after spinal cord injury. Physiology (Bethesda) (2008) 0.90
Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering. Neuropathology (2008) 0.89